Should synovectomy be performed in primary total knee arthroplasty for osteoarthritis? A meta-analysis of randomized controlled trials
Journal of Orthopaedic Surgery and Research volume 14, Article number: 283 (2019)
During primary total knee arthroplasty (TKA), synovectomy as a part of the procedure has been recommended to relieve pain and inflammation of the synovium, but there is a controversy about it due to increased bleeding. In this meta-analysis, the aim is to answer whether synovectomy should be performed routinely during TKA for symptomatic knee osteoarthritis (KOA).
Relevant randomized controlled trials (RCTs) on synovectomy were retrieved through database searches of PubMed, Embase, Web of Science, and Cochrane Library up to February 2019. Studies that compared postoperative pain, clinical Knee Society Score (KSS), functional KSS, range of motion (ROM), drainage, pre- and postoperative hemoglobin difference, transfusion rate, operative time, and/or complications were included in the meta-analysis. Review Manager 5.3.0 was used for meta-analysis.
We included 5 RCTs with 542 knees. Pooled results indicated that the synovectomy group was associated with more blood loss via drainage (WMD = − 99.41, 95% CI − 153.75 to − 45.08, P = 0.0003) and pre- and postoperative hemoglobin difference (WMD = − 0.93, 95% CI − 1.33 to − 0.5, P < 0.00001), compared with the non-synovectomy group. No statistically significant differences were demonstrated between both groups in postoperative pain, clinical KSS, functional KSS, ROM, transfusion rate, or complications (P > 0.05).
The current evidence demonstrates that performing synovectomy in primary TKA for symptomatic KOA does not have any clinical benefit. It increases postsurgical blood loss. Surgeons routinely undertaking synovectomy should deliberate whether this is clinically indicated and consider limiting resection, if possible.
Synovium is indispensable for the apposite function of the locomotor system. It secretes the slimy synovial fluid, which lubricates the joint and nourishes the articular cartilage. Pathologically, synovitis exacerbates chondral degeneration in osteoarthritis (OA) and inflammatory joint diseases . Clinical , radiological , and pathological  evidence of inflammatory processes in OA undermine its definition as a non-inflammatory disease. For inflammatory joint diseases (such as rheumatoid arthritis), synovectomy can effectively relieve pain and improve postoperative function . Could synovectomy be equally necessary for knee osteoarthritis (KOA)? The literature currently lacks agreement on this subject.
Synovectomy is performed during primary total knee arthroplasty (TKA) for KOA mainly in the light of a surgeon’s experience and preference . Orthopedic surgeons administering synovectomy claim that synovitis is the main cause of knee joint swelling and pain . In addition, synovial inflammation is a risk factor for unsatisfactory results after TKA , because it restricts the range of motion , and is associated with recurrent knee hemarthrosis and impingement . In contrast, opponents prefer to avoid synovectomy. They question the clinical advantages of the procedure, considering that it prolongs operative time, increases blood loss, and induces infection [11, 12].
Previous studies have compared the outcomes of KOA patients after primary TKA with versus without synovectomy [13, 14]. However, these studies had the following deficiencies. First, few studies were included, and the quality was not reliable. Second, involved outcomes were inadequate, and safety of synovectomy was not performed. Third, inclusion of new studies might alter the results of previous meta-analyses. Therefore, re-evaluation of this subject is necessary. Our new meta-analysis completely retrieved the studies, selected high-quality ones, and evaluated both the effectiveness and safety of synovectomy.
This meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) checklist. No ethical approval was required.
We search all articles on synovectomy for treating KOA patients in electronic databases, including PubMed, Embase, Cochrane Library, and Web of Science, up to February 2019. In addition, a manual search of bibliographies of identified articles was executed to determine potentially relevant studies. A structured search was performed using this following search string: (Synovectomy OR Synovectomies OR Synovium Resection OR Resection, Synovium OR Synovium Resections [Mesh Terms]) AND (TKA OR TKR OR total knee arthroplasty OR total knee replacement [Title/Abstract]). Our search did not cover language or publication time restrictions.
Inclusion and exclusion criteria
Studies were selected for meta-analysis if they met the following Population, Intervention, Comparator, Outcome, and Study design (PICOS) criteria: Population—KOA patients scheduled for primary TKA; Intervention—TKA with synovectomy; Comparison—TKA without synovectomy; Outcomes—post-operative pain, clinical KSS, functional KSS, ROM, drainage, pre- and postoperative hemoglobin difference, transfusion rate, operative time, and complications; Study design—RCTs.
Studies were ruled out if any of the following existed: non-conformance to inclusion criteria, low-quality RCTs and non-RCTs, undefined sample and control sources, non-therapeutic clinical studies, non-original studies, non-full-text reports, and undefined grouping.
Standard data extraction was carried out to collect the following data from included trials: author’s name, publication year, sample size, age, gender, BMI, intervention, control group, outcomes, study design, and follow-up. Relevant data were extracted independently by two authors (Feifan Lu and Ziqi Xia) after all eligible studies were identified. In studies in which data were incomplete or unclear, attempts were made to contact investigators for clarification. All data were extracted; any discrepancy was cross-checked and resolved by a third author (Weiguo Wang) to reach a final consensus.
In accordance with the Cochrane Handbook for Systematic Reviews of Interventions, two reviewers (Huachen Yu and Qidong Zhang) independently assessed the risk of bias, including the following items: random sequence generation, allocation concealment, blinding of participants, blinding of outcome assessor, incomplete outcome data, reporting bias, and other bias. Each item was measured as low, unclear, or high bias. The risk-of-bias summary and risk-of-bias graph were generated with Review Manager 5.3.0 software (Nordic Cochrane Centre, Cochrane Collaboration, Copenhagen, Denmark).
The results of selected studies were pooled for meta-analysis when two or more results were available. Continuous data were entered as means and standard deviations, and dichotomous outcomes as the number of events. Continuous outcomes were expressed as weighted mean differences (WMD) and 95% confidence intervals (CI). Dichotomous data were stated as relative ratios (RR) and 95% CI. The level of statistical significance was established at P < 0.05. The Q and chi-square tests were used to estimate statistical heterogeneity with the values of P and I2. If I2 was > 50% and P was < 0.1, a random effects model was utilized. Otherwise, a fixed effects model was applied. Publication bias was evaluated with funnel plot and Egger’s test.
A total of 974 pertinent studies were identified with our search strategy; 3 additional reports were found during the manual search of references. Six hundred thirty-five duplicate studies were excluded with Endnote Software (Version X8, Thompson Reuters, CA, USA). Additional 183 studies were removed after review of the title and abstract. We excluded 154 studies after reading the full text because they did not meet the inclusion criteria. The remaining 5 studies were selected in this meta-analysis. The PRISMA flow diagram is presented in Fig. 1.
Description of included studies and quality assessment
The including five trials [15,16,17,18,19] were single-centered RCTs. A total of 542 knees were involved, with an average age of 69 years, and length of follow-up from 26 weeks to 1 year. Visual analog scale (VAS) was used to evaluate postoperative pain. The most commonly adopted knee functional scores were clinical KSS, functional KSS, and ROM. Indicators of blood loss included drainage, pre- and postoperative hemoglobin difference, and transfusion rate. Two studies reported operative time and complications. The detailed information can be seen in Table 1.
The quality of evidence was evaluated with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach described in the Cochrane Handbook for Systematic Reviews of Intervention. The risk of bias varied among studies, but all contained moderate- to high-quality evidence with a low risk of bias (Fig. 2).
Results of meta-analysis
Three studies [16, 17, 19], including 435 knees, evaluated postoperative pain. Statistical heterogeneity was found in VAS (I2 = 95%, P < 0.00001), and a random effects model was applied. Pooled results showed no significant difference between the synovectomy group and control group in terms of postoperative pain (WMD = 0.08, 95% CI − 0.96 to 1.13, P = 0.88; Fig. 3).
We evaluated postoperative function using clinical KSS (two studies [17, 18] involving 254 knees), functional KSS (three studies [17,18,19] involving 354 knees), and ROM (three studies [15, 17, 19] with 327 knees). There was no significant heterogeneity between both groups, and thus, we used a fixed effects model. No significant difference was found in clinical KSS (WMD = 0.04, 95% CI − 2.63 to 2.71, P = 0.98), functional KSS (WMD = 0.52, 95% CI − 0.78 to 1.82, P = 0.43), and ROM (WMD = − 0.12, 95% CI − 5.11 to 4.87, P = 0.96; Fig. 4).
Blood loss was evaluated via drainage (two studies [17, 19], 287 knees), pre- and postoperative hemoglobin difference (three studies [15,16,17], 375 knees), and transfusion rate (three studies [15,16,17], 375 knees). Pooled results indicated that synovectomy was associated with greater drainage (WMD = − 99.41, 95% CI − 153.75 to − 45.08, P = 0.0003) and pre- and postoperative hemoglobin difference (WMD = − 0.93, 95% CI − 1.33 to − 0.5, P < 0.00001), but no significant difference in transfusion rate (RR = 0.88, 95% CI 0.63 to 1.23, P = 0.45) between the two compared groups. A fixed effects model was applied according to statistical heterogeneity. The detailed information can be viewed in Fig. 5.
Two studies [15, 16], involving 188 knees, reported complications. A fixed effects model was utilized (I2 = 9%, P = 0.30). No significant difference in complications was observed between the two compared groups (RR = 0.63, 95% CI 0.27 to 1.50, P = 0.30; Fig. 6).
Publication bias and sensitivity analysis
We used Egger’s test of funnel plot to investigate the possibility of publication bias, which shows that there was no significant bias in any measured outcomes. Unfortunately, sensitivity analysis was not performed because of scant literature.
The main finding observed is that compared with non-synovectomy, synovectomy in primary TKA generates no clinical benefits. Our pooled data showed that synovectomy increased blood loss. In addition, we found no significant difference in regard to postoperative pain, function, and complications between the two groups.
The potential benefits of synovectomy for the management of KOA are currently debatable. In recent years, the pathogenesis of KOA is extending from a disease of cartilage to one of the “whole joint” . The cartilage, bone, and synovium are each involved in pathological processes that result in advanced joint deterioration. Resection of the synovium may theoretically have beneficial effects. From a clinical standpoint, case series of arthroscopic debridement and synovectomy in the moderate to severe stages of KOA have shown some benefits [21, 22]. However, these were impermanent owing to the relentless progressive nature history of the KOA . Therefore, TKA is the most common and effective selection for symptomatic end-stage KOA. Fernandez-Madrid et al.  suggest that synovitis might be a risk cause of pain, and it has been proposed that surgical synovectomy can relieve pain and improve function after TKA. Synovectomy has advantageous effects, but also adverse effects. Bernal-Fortich et al.  report that synovectomy increases the amount of bleeding after the procedure, with a difference of 9 g/l of pre- and postoperative hemoglobin. Tanavalee et al.  conclude that synovectomy in TKA does not shorten the duration of the inflammatory response after surgery.
Conflicting results were discovered assessing postoperative pain. The RCT of Zhaoning et al.  described no differences in postoperative pain at 24 h, 3 days, and 4 weeks in KOA patients with or without synovium resection (P > 0.05). Kilicarslan et al.  found that the VAS score at 3 months was lower in the synovium-retaining group. Bernal-Fortich et al.  reported that postoperative pain was significantly lower in the synovectomy group at 24 h and 48 h (P < 0.001). However, the difference was statistically significant; it was not clinically relevant. In our meta-analysis, pooled results showed no significant difference in postoperative pain between synovectomy and non-synovectomy groups. However, there was high heterogeneity among the included studies. The source of heterogeneity may be due to different analgesic methods in the perioperative period.
TKA is performed to remove damaged articular cartilage and subchondral bone and to restore alignment, which may be why the procedure is so effective for most patients. However, satisfaction analyses show that at least 20% of patients are unsatisfied with their knee outcomes . We used clinical KSS, functional KSS, and ROM to evaluate the postoperative knee function. Pooled results showed no significant difference in postoperative function between both groups. Zhaoning et al. observed no difference in clinical KSS, functional KSS, and ROM between the preservation and resection group . The study by Rakin et al. also found no difference in ROM (P = 0.602) and health score (81.00 versus 85.63) at 1 year between patients with or without synovectomy .
Our meta-analysis demonstrates that synovectomy can be carried out safely during TKA with no detrimental effects. The risks of synovectomy include longer operative time, extra blood loss, more blood transfusion rate, and added complications. We concluded that blood loss via drainage and pre- and postoperative hemoglobin difference was greater in the synovectomy group. Many studies agree with our findings in term of blood loss [6, 13]. An accurate synovectomy technique is vital to prevent blood loss. First, precise tissue planes are identified. Secondly, it is important to remove the subintimal and intimal layers but to leave the vascular layer intact . Except for surgical technique, many risk factors such as patient’s gender, prosthesis type, femoral plug usage, additional medical comorbidities, and thromboembolism prophylaxis influence blood loss [26, 27]. Conflicting evidence was described evaluating operative time. The study by Zhaoning et al. found that the mean operative time was longer in the synovectomy group (1.50 h (1.34 to 1.75) vs 1.41 h (1.21 to 1.79), P = 0.006) . Kilicarslan et al. observed no differences between the sides in mean operative time . Synovectomy is associated with increased operative time, mainly owing to the added time of removal of the synovium and hemostasis. However, pooled data do not demonstrate that increased operative time and extra blood loss translate to more complications and blood transfusion rate.
Some limitations of this meta-analysis must be recognized. First, a relatively small number of studies and a limited number of sample sizes have weakened the objective evaluation. Second, partial RCTs lacked descriptions of random sequence generation, allocation concealment, and blinding methods, which decreased the robustness of the analysis. Third, as predictors of postoperative pain and function, presurgical patient factors were not evaluated  because of the lack of raw data. Fourth, the follow-up duration was relatively short; long-term follow-up was needed. Finally, the included studies used different treatment modalities of perioperative nursing and rehabilitation which could have affected results. This meta-analysis did not evaluate these factors; further evaluation is necessary in future studies.
In conclusion, our meta-analysis has demonstrated that clinical outcomes between synovectomy and non-synovectomy are equivalent, with the exception of the increased blood loss. However, synovectomy is safe. It has no effect on postoperative pain and function, complications, and blood transfusion rate. While these findings may not mean the need for immediate clinical changes, research spurred by these outcomes may eventually lead to clinical changes, if these are valid.
Availability of data and materials
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
Grading of Recommendations Assessment, Development, and Evaluation
Knee Society Score
Preferred Reporting Items for Systematic Reviews and Meta-analyses
Randomized controlled trial
Range of motion
Total knee arthroplasty
Visual analog scale
Weighted mean differences
Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil. 2013;21:16–21. https://doi.org/10.1016/j.joca.2012.11.012.
Ayral X, Pickering EH, Woodworth TG, et al. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis – results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthr Cartil. 2005;13:361–7. https://doi.org/10.1016/j.joca.2005.01.005.
Atukorala I, Kwoh CK, Guermazi A, et al. Synovitis in knee osteoarthritis: a precursor of disease? Ann Rheum Dis. 2016;75:390–5. https://doi.org/10.1136/annrheumdis-2014-205894.
Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51:249–57. https://doi.org/10.1016/j.bone.2012.02.012.
Tanaka N, Sakahashi H, Sato E, et al. Influence of the infrapatellar fat pad resection in a synovectomy during total knee arthroplasty in patients with rheumatoid arthritis. J Arthroplast. 2003;18:897–902. https://doi.org/10.1016/s0883-5403(03)00271-7.
Auso-Perez JR, Rodriguez-Blanes GM. Influence of synovectomy on blood loss and need for transfusion in standard total knee replacement. Eur J Orthop Surg Traumatol. 2018;28:1151–6. https://doi.org/10.1007/s00590-018-2160-8.
Malkoc M, Korkmaz O. Results of arthroscopic synovectomy for treatment of synovial lipomatosis (lipoma arborescens) of the knee. J Knee Surg. 2018;31:536–40. https://doi.org/10.1055/s-0037-1604440.
Attur M, Samuels J, Krasnokutsky S, et al. Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence? Best Pract Res Clin Rheumatol. 2010;24:71–9. https://doi.org/10.1016/j.berh.2009.08.011.
Matsumoto T, Fujita K, Fujioka H, et al. Massive nonspecific olecranon bursitis with multiple rice bodies. J Shoulder Elb Surg. 2004;13:680–3. https://doi.org/10.1016/j.jse.2004.03.008.
Ohdera T, Tokunaga M, Hiroshima S, et al. Recurrent hemarthrosis after knee joint arthroplasty. J Arthroplast. 2004;19:157–61. https://doi.org/10.1016/j.arth.2003.09.009.
Kim JL, Park JH, Han SB, et al. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplast. 2017;32:320–5. https://doi.org/10.1016/j.arth.2016.08.026.
Lee GC. What’s new in adult reconstructive knee surgery. J Bone Joint Surg Am. 2018;100:166–75. https://doi.org/10.2106/JBJS.17.01148.
Kooner SS, Clark M. The effect of synovectomy in total knee arthroplasty for primary osteoarthritis: a meta-analysis. J Knee Surg. 2017;30:289–96. https://doi.org/10.1055/s-0036-1584560.
Zhao ZQ, Xu J, Wang RL, et al. The efficacy of synovectomy for total knee arthroplasty: a meta-analysis. J Orthop Surg Res. 2018;13:51. https://doi.org/10.1186/s13018-018-0752-y.
Rankin KS, Ramaskandhan J, Bardgett M, et al. Synovectomy during total knee arthroplasty: a pilot single-centre randomised controlled trial. Pilot Feasibility Stud. 2018;4:145. https://doi.org/10.1186/s40814-018-0336-y.
Bernal-Fortich LD, Aguilar CA, Rivera-Villa AH, et al. A prospective randomized trial of total synovectomy versus limited synovectomy in primary total knee arthroplasty: evaluation of bleeding, postoperative pain, and quality of life with SF-12 v2. Eur J Orthop Surg Traumatol. 2018;28:701–6. https://doi.org/10.1007/s00590-018-2139-5.
Zhaoning X, Xu Y, Shaoqi T, et al. The effect of synovectomy on bleeding and clinical outcomes for total knee replacement. Bone Joint J. 2013;95-B:1197–200. https://doi.org/10.1302/0301-620X.95B9.31253.
Tanavalee A, Honsawek S, Rojpornpradit T, et al. Inflammation related to synovectomy during total knee replacement in patients with primary osteoarthritis: a prospective, randomised study. J Bone Joint Surg Br. 2011;93:1065–70. https://doi.org/10.1302/0301-620X.93B8.26719.
Kilicarslan K, Yalcin N, Cicek H, et al. The effect of total synovectomy in total knee arthroplasty: a prospective randomized controlled study. Knee Surg Sports Traumatol Arthrosc. 2011;19:932–5. https://doi.org/10.1007/s00167-010-1270-6.
Ashraf S, Cha BH, Kim JS, et al. Regulation of senescence associated signaling mechanisms in chondrocytes for cartilage tissue regeneration. Osteoarthr Cartil. 2016;24:196–205. https://doi.org/10.1016/j.joca.2015.07.008.
Li ZM, Li M. Improvement in orthopedic outcome score and reduction in IL-1beta, CXCL13, and TNF-alpha in synovial fluid of osteoarthritis patients following arthroscopic knee surgery. Genet Mol Res. 2017;16. https://doi.org/10.4238/gmr16039487.
Su X, Li C, Liao W, et al. Comparison of arthroscopic and conservative treatments for knee osteoarthritis: a 5-year retrospective comparative study. Arthroscopy. 2018;34:652–9. https://doi.org/10.1016/j.arthro.2017.09.023.
Steadman JR, Briggs KK, Matheny LM, et al. Ten-year survivorship after knee arthroscopy in patients with Kellgren-Lawrence grade 3 and grade 4 osteoarthritis of the knee. Arthroscopy. 2013;29:220–5. https://doi.org/10.1016/j.arthro.2012.08.018.
Fernandez-Madrid F, Karvonen RL, Teitge RA, et al. Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Magn Reson Imaging. 1995;13:177–83.
Maratt JD, Lee YY, Lyman S, et al. Predictors of satisfaction following total knee arthroplasty. J Arthroplast. 2015;30:1142–5. https://doi.org/10.1016/j.arth.2015.01.039.
Liu D, Dan M, Martinez Martos S, et al. Blood management strategies in total knee arthroplasty. Knee Surg Relat Res. 2016;28:179–87. https://doi.org/10.5792/ksrr.2016.28.3.179.
Hart A, Khalil JA, Carli A, et al. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am. 2014;96:1945–51. https://doi.org/10.2106/JBJS.N.00077.
Lenguerrand E, Wylde V, Gooberman-Hill R, et al. Trajectories of pain and function after primary hip and knee arthroplasty: the ADAPT cohort study. PLoS One. 2016;11:e0149306. https://doi.org/10.1371/journal.pone.0149306.
We thank Rebecca Tollefson, DVM, from Liwen Bianji, Edanz Editing China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.
This study was funded by the National Natural Science Foundation of China (grant number 81703896, 81673776), the Capital Health Research and Development of Special (grant number 2016-2-4062), the Beijing Municipal Science and Technology Commission (grant number Z171100001017209), and the National Key Research and Development Program of China (grant number 2017YFC0108102).
This study dealt with published data only; no ethical approval was needed.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Liu, P., Lu, F., Chen, J. et al. Should synovectomy be performed in primary total knee arthroplasty for osteoarthritis? A meta-analysis of randomized controlled trials. J Orthop Surg Res 14, 283 (2019). https://doi.org/10.1186/s13018-019-1332-5
- Total knee arthroplasty